VAERS reports by lot

Pfizer COVID-19 lot EWO182: VAERS reports

43 VAERS reports list lot EWO182 as a Pfizer COVID-19 vaccine, received between 2021-05-06 and 2024-11-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
43
Reports
19%
Marked serious
1
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5424%
Cardiac / Cardiovascular4520%
Neurological3716%
Gastrointestinal177%
Musculoskeletal177%
Respiratory125%
Dermatological (non-injection-site)104%
Injection-site / Local reaction104%
Psychiatric / Neuropsychiatric94%
Allergic / Anaphylactic63%
Autoimmune / Immune-mediated52%
Thrombotic / Hematological42%
Reproductive / Menstrual21%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
New Jersey5
Michigan4
New York3
Florida3
Minnesota3
Kentucky2
Oregon2
Washington2
Missouri2
Colorado1
Ohio1

Reports by month received

2021-0512
2021-068
2021-071
2021-084
2021-095
2021-101
2021-114
2021-121
2022-013
2022-021
2022-041
2022-091
2024-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.